542
Participants
Start Date
December 16, 2011
Primary Completion Date
August 26, 2013
Study Completion Date
August 26, 2013
AZD6765 iv
50 mg (AZD6765 Solution for Infusion, 0.5 mg/mL) by iv infusion.
AZD6765 iv
100 mg (AZD6765 Solution for Infusion, 1.0 mg/mL) by iv infusion.
Placebo
0.9 sodium chloride \[normal saline\] solution for injection by iv infusion
Research Site, Chino
Research Site, Lond Beach
Research Site, San Diego
Research Site, Stanford
Research Site, New Heaven
Research Site, Fort Lauderdale
Research Site, Gainsville
Research Site, Lake City
Research Site, Miami
Research Site, Orlando
Research Site, St. Petersburg
Research Site, Atlanta
Research Site, Decatur
Research Site, Hoffman Estates
Research Site, Joliet
Research Site, Skokie
Research Site, Lake Charles
Research Site, Shreveport
Research Site, Baltimore
Research Site, Boston
Research Site, Minneapolis
Research Site, St Louis
Research Site, Willingboro
Research Site, Mount Kisco
Research Site, New York
Research Site, Rochester
Research Site, Winston-Salem
Research Site, Cincinnati
Research Site, Dayton
Research Site, Philadelphia
Research Site, Dallas
Research Site, Houston
Research Site, Bellevue
Research Site, Antofagasta
Research Site, Santiago
Research Site, Bratislava
Research Site, Liptovský Mikuláš
Research Site, Michalovce Stranany
Research Site, Rimavská Sobota
Research Site, Svidník
Research Site, Trnava
Research Site, Cape Town
Research Site, Johannesburg
Research Site, Tygervalley
Lead Sponsor
AstraZeneca
INDUSTRY